Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    Open Studies | Exclude Unknown | Down syndrome, Alzheimer
Show Display Options
Rank Status Study
1 Recruiting Nicotine Treatment of Cognitive Decline in Down Syndrome
Conditions: Down Syndrome;   Mild Cognitive Impairment
Interventions: Drug: Low Dose Nicotine (7mg);   Drug: Moderate Dose Nicotine (14mg)

Indicates status has not been verified in more than two years